MedPath

High-Flow Nasal Oxygenation Versus Standard Oxygenation in Gastrointestinal Endoscopy With Sedation.

Not Applicable
Completed
Conditions
Gastrointestinal Endoscopy
Sedation
Interventions
Device: High-flow nasal cannula oxygenation group
Registration Number
NCT03829293
Lead Sponsor
Centre Hospitalier Régional d'Orléans
Brief Summary

This study is a randomized controlled trial comparing high-flow nasal oxygen therapy (HFNO) versus standard oxygen therapy (nasal prongs, nasopharyngeal catheter or standard face mask) during gastrointestinal (GI) endoscopy with sedation to reduce the incidence of hypoxia.

Detailed Description

Hypoxemia is the most common complication during a gastrointestinal endoscopy with sedation. Oxygenation is usually applied during the procedure to prevent the occurrence of desaturation. Conventional oxygen is typically administered by conventional nasal cannula, by nasopharyngeal catheter or by a facemask with mild flow of oxygen. The flow of standard oxygen is limited to 15L/min.

High-flow nasal cannula oxygenation is a new method of humidified and heated oxygenation with a higher flow rates (up to 70L/min).

The primary outcome will be the incidence of hypoxia defined by pulsed saturation with oxygen (SpO2) ≤92%. The investigator's hypothesis is that high-flow nasal oxygen therapy will decrease the frequency of hypoxemia during gastrointestinal endoscopy under sedation.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
380
Inclusion Criteria
  • Age greater than or equal to 18 years
  • Having GI endoscopy expected under sedation
  • At risk of hypoxia defined by (one of the item): an underlying cardiac disease ; an underlying respiratory disease ; age greater than or equal to 60 years ; ASA II, III or ASA IV ; with an body mass index greater or equal to 30 (kg/m²); with sleep apnea syndrome diagnosed or suspected with a STOP-BANG score ≥ 3
Read More
Exclusion Criteria
  • Age below 18
  • Emergency GI endoscopy
  • Need of intubation for the procedure
  • Patient with chronic oxygen treatment
  • Patients with tracheostomy
  • Pregnancy, breastfeeding
  • Not affiliated to French social security
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
High-flow nasal cannula oxygenation groupHigh-flow nasal cannula oxygenation groupParticipants in the experimental group will receive high-flow nasal oxygen therapy (HFNO) during gastrointestinal endoscopy under sedation (with a flow at 70L/min and oxygen inspired fraction (FiO2) 50%) through a dedicated system, the THRIVETM (Fisher\&Paykel, New-Zealand)
Primary Outcome Measures
NameTimeMethod
Incidence of hypoxiaDuration of GI endoscopy procedure under sedation, an expected average of 2 hours

SpO2 ≤ 92%

Secondary Outcome Measures
NameTimeMethod
Failure of the endoscopic procedureDuration of GI endoscopy procedure under sedation, an expected average of 2 hours

Number of patients in whom the endoscopic procedure has to be stopped and postponed

Duration of sedationDuration of GI endoscopy procedure under sedation, an expected average of 2 hours

From anaesthesia induction to the awakening of the patient, in minutes

Incidence of hypoxia in the recovery roomLength of stay in the recovery room, an expected average of 2 hours

SpO2 ≤ 92%

Incidence of apnea during the procedureDuration of GI endoscopy procedure under sedation, an expected average of 2 hours

Breath rate ≤6/min

Incidence of hypoxia with SpO2 ≤ 90%Duration of GI endoscopy procedure under sedation, an expected average of 2 hours

SpO2 ≤ 90%

Prolonged hypoxia during the procedureDuration of GI endoscopy procedure under sedation, an expected average of 2 hours

SpO2 ≤ 92% for ≥60 s

Temporal course of SpO2Duration of GI endoscopy procedure under sedation, an expected average of 2 hours

Absolute changes in SpO2

Duration of the endoscopic procedureDuration of GI endoscopy procedure under sedation, an expected average of 2 hours

From insertion of the fiberoptic endoscope to its withdrawal, in minutes

Severe hypoxia during the procedureDuration of GI endoscopy procedure under sedation, an expected average of 2 hours

SpO2 ≤ 90% and SpO2 ≤85%

Temporal course of heart rateDuration of GI endoscopy procedure under sedation, an expected average of 2 hours

Absolute changes in heart rate, in bpm

Incidence of bradycardiaDuration of GI endoscopy procedure under sedation, an expected average of 2 hours

Heart rate \< 50 bpm

Incidence of need for mechanical respiratory supportDuration of GI endoscopy procedure under sedation, an expected average of 2 hours

noninvasive ventilation, or ventilation through a laryngeal mask, or tracheal intubation

Length of stay in the recovery roomLength of stay in the recovery room, an expected average of 2 hours

From admission at to discharge from the recovery room, in minutes

Incidence of severe hypoxiaDuration of GI endoscopy procedure under sedation, an expected average of 2 hours

SpO2 ≤ 85%

Modification of oxygenation during the procedureDuration of GI endoscopy procedure under sedation, an expected average of 2 hours

Increase of oxygen flow in conventional group or FiO2 in the interventional group to maintain an adequate oxygenation

The need of intervention by the anesthesia teamDuration of GI endoscopy procedure under sedation, an expected average of 2 hours

Need of airway manipulation, use of noninvasive ventilation or mechanical invasive ventilation

Temporal course of respiratory rateDuration of GI endoscopy procedure under sedation, an expected average of 2 hours

Absolute changes in respiratory rate, in cycles/minutes

Temporal course of arterial blood pressureDuration of GI endoscopy procedure under sedation, an expected average of 2 hours

Absolute changes arterial blood pressure, in mmHg

Need of hospitalisation24 hours

percentage of ambulatory patients who needed to be hospitalised after the procedure

Serious adverse event rate24 hours

Percentage of patients experiencing at least one serious adverse event

Trial Locations

Locations (3)

Hospital Center of DAX

🇫🇷

DAX, France

Pole santé ORELIANCE

🇫🇷

Orléans, France

Orleans Hospital Center

🇫🇷

Orléans, France

© Copyright 2025. All Rights Reserved by MedPath